

Dynavax to Present at the 31st Annual J.P. Morgan Healthcare Conference
December 17, 2012 09:30 ET
Dynavax to Present at the 31st Annual J.P. Morgan Healthcare Conference
BERKELEY, CA--(Marketwire - Dec 17, 2012) - Dynavax Technologies Corporation (
Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at [ http://investors.dynavax.com/newsevents.cfm ].
About Dynavax
Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine. For more information visit [ www.dynavax.com ].